Alqifari, S.F.; Gari, M.H.; Guo, J.J.; Alamin, S.; Esmail, A.K.; Esmail, A.K.; Hamad, H.R.; Aljabri, A.; Alatawi, A.M.; Albishi, L.A.;
et al. Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023. Diseases 2025, 13, 208.
https://doi.org/10.3390/diseases13070208
AMA Style
Alqifari SF, Gari MH, Guo JJ, Alamin S, Esmail AK, Esmail AK, Hamad HR, Aljabri A, Alatawi AM, Albishi LA,
et al. Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023. Diseases. 2025; 13(7):208.
https://doi.org/10.3390/diseases13070208
Chicago/Turabian Style
Alqifari, Saleh F., Musaab Habibulla Gari, Jeff J. Guo, Shoroq Alamin, Aya K. Esmail, Abdullah K. Esmail, Heba R. Hamad, Ahmed Aljabri, Amirah M. Alatawi, Laila A. Albishi,
and et al. 2025. "Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023" Diseases 13, no. 7: 208.
https://doi.org/10.3390/diseases13070208
APA Style
Alqifari, S. F., Gari, M. H., Guo, J. J., Alamin, S., Esmail, A. K., Esmail, A. K., Hamad, H. R., Aljabri, A., Alatawi, A. M., Albishi, L. A., Alraddadi, M. O., & Hetta, H. F.
(2025). Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023. Diseases, 13(7), 208.
https://doi.org/10.3390/diseases13070208
